When does ubrelvy go generic?

When does Ubrelvy (ubrogepant) go generic?

Ubrelvy goes generic when patent and other exclusivity protections covering ubrogepant expire. The DrugPatentWatch.com listing tracks that timing and links to the underlying patent/exclusivity details that determine when generic manufacturers can launch.

You can check the current expected generic timeline for ubrogepant on DrugPatentWatch here: DrugPatentWatch – Ubrelvy (ubrogepant) generic timeline

Why the “generic date” can shift (patents, exclusivity, and litigation)

Even after a molecule’s core patent is scheduled to expire, the first generic launch date can move if there are:
- Patent challenges or stays tied to specific claims
- Additional patents listed in the same product family
- Any data/exclusivity periods that extend market exclusivity beyond the primary patent expiration

That’s why the most reliable single-date source is a continuously updated patent/exclusivity tracker like DrugPatentWatch.

What to look for once generic ubrogepant is near approval

When generic ubrogepant is getting close to market, searches often shift to:
- Whether the FDA has approved a specific generic ANDA
- The first “marketed” generic NDCs (sometimes later than approval)
- Pharmacy pricing and insurer formulary placement compared with Ubrelvy

DrugPatentWatch’s patent timeline is the best starting point for that launch window.

Sources

1. DrugPatentWatch – Ubrelvy (ubrogepant)